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INTRODUCTION
Human metapneumovirus (HMPV), a recently discovered
member of the family Paramyxoviridae, has been isolated from
the respiratory secretions of patients worldwide (1-4). Though
not as common as respiratory syncytial virus (RSV), it is a fre-
quent etiologic agent of both upper and lower respiratory tract
infections. Evidence suggests that this virus has been circulat-
ing for over 50 yr and most individuals have been exposed to
it by the age of 5 (5). However, the epidemiological picture
of HMPV infections in Korean children remains unclear.
RSV is a common cause of respiratory illness in children,
and is considered the most important cause of viral bronchi-
olitis in young children (6). Several studies have shown clin-
ical manifestations of HMPV and RSV infections to be very
similar, and range from mild respiratory problems to bron-
chiolitis, pneumonia, severe cough, high fever, and myalgia;
consequently, they are difficult to distinguish clinically (5,
7). RSV is known as a major causative agent of acute wheez-
ing in children, and RSV bronchiolitis in early childhood is
strongly associated with asthma development later in life (8).
Several research groups have reported HMPV is also an eti-
ologic agent of wheezing illness in children and adults (9-12),
though there have been contradictory results (13).
RSV and HMPV share genomic (14) and seasonal distribu-
tion (15, 16) patterns, as well. Both viruses circulate in the
winter and spring months with recurrent epidemics occur-
ring in the winter. Studies have also shown that HMPV caus-
es persistent infections, as does RSV, due to these viruses elic-
iting only a partially protective immune response (17). Because
of their clinical, genetic, and epidemiological homogeneity,
it has been suggested they also share similar replicative, patho-
physiologic, and immunologic functions (14). To date this
question remains unanswered.
In our previous report, HMPV was found to be prevalent
in Korean children ≤5 yr hospitalized with acute wheezing
illness from February to November 2006 (12). This study
investigated the relative contribution of HMPV to the hos-
pitalization of children for acute wheezing illness and to fur-
ther elucidate the clinical and epidemiological differences of
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Clinical and Epidemiological Comparison of Human Metapneumovirus
and Respiratory Syncytial Virus in Seoul, Korea, 2003-2008
Human metapneumovirus (HMPV) shares clinical and epidemiological character-
istics with well-known respiratory syncytial virus (RSV). The aim of this study was
to investigate the clinical and epidemiological differences between HMPV- and RSV-
induced wheezing illnesses. A total of 1,008 nasopharyngeal aspirate specimens
was collected from 1,008 pediatric patients hospitalized with acute respiratory tract
infection at Inje University Sanggye Paik Hospital from December 2003 to April 2008,
and tested for seven common respiratory viruses. Conditions classified as wheez-
ing illness were bronchiolitis, reactive airways disease, and bronchial asthma. HMPV
caused a significantly lower proportion of wheezing illness when compared to RSV
(48.1% vs. 82.2%, P<0.05). HMPV-induced wheezing illness occurred predomi-
nantly in older patients when compared to RSV patients (P<0.001). RSV infections
peaked in the fall and winter followed by peaks of HMPV infection in winter and spring.
Eosinophil counts were significantly higher (P<0.01) in RSV patients when compared
to HMPV patients. These results show that human metapneumovirus patients exhib-
it several different clinical and epidemiological characteristics, such as higher pro-
portion of wheezing illness, age and seasonal incidence, and eosinophil counts,
when compared to RSV patients.
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HMPV infection in relation to RSV infection from Decem-
ber 2003 to April 2008. 
MATERIALS AND METHODS
Study population
A total of 1,008 nasopharyngeal aspirate (NPA) specimens
were collected from 1,008 pediatric patients hospitalized with
acute respiratory tract infection wheezing illness at Inje Uni-
versity Sanggye Paik Hospital from December 2003 to April
2008. For this study, three different diagnoses were classifi-
ed as wheezing illness: bronchiolitis, reactive airways disease
(RAD) and bronchial asthma. Acute bronchiolitis was defin-
ed as a first occurrence of expiratory wheezing with or with-
out tachypnea, air trapping, and substernal retraction in chil-
dren <3 yr of age. RAD was defined as recurrent wheezing
<3 times, and bronchial asthma was defined as recurrent wheez-
ing ≥3 times in any child (18). Informed consent was given
before any specimens were taken and the study protocol was
approved by the Ethics Committee of Inje University Sang-
gye Paik Hospital (IRB # IJ 06-34).
On admission, 2 mL of normal saline were instilled into
the nostril and then aspirated using a disposable catheter and
suction device. NPAs were centrifuged and the supernatants
were stored at -70℃until tested.
Viral detection
From December 2003 to December 2006, common res-
piratory viruses (Adenovirus, RSV, Influenza A and B, and
Parainfluenza viruses 1-3) were detected by immunofluores-
cent-antibody test (IFA) (DAKO, Cambridgeshire, UK), while
HMPV was detected using multiplex reverse transcriptase-
polymerase chain reaction (RT-PCR), as previously describ-
ed (12). From January 2007 to the end of the study period,
RT-PCR was used to test all respiratory viruses investigated,
including Rhinovirus (RV).
Statistical analysis
The chi-square test was used to compare results for the virus-
es tested, and all analyses were done using SPSS version 10.0
(SPSS, Inc., Chicago, IL, USA). Differences were considered
significant when Pvalues were less than 0.05. 
RESULTS
Study population
From December 2003 to April 2008, 1,008 nasopharyn-
geal aspirates were taken from pediatric patients hospitaliz-
ed for acute respiratory tract infection and tested for six com-
mon viruses (RSV, parainfluenza, HMPV, adenovirus, and
influenza A and B). RV was tested for from January 2007 to
April 2008. 
HMPV and RSV prevalence
From the above study group, HMPV had an overall preva-
lence of 7.2% (73/1,008) while prevalence of RSV was 26.0%
(262/1,008). 
Patient demographics
The average age of first infection in the HMPV and RSV
groups are shown in Table 1. Virus-positive patients hospital-
ized with acute respiratory tract infection had an average age
of 20.2±21.0 months (range, 1-150 months). The most com-
monly detected virus was RSV (25.5%) followed by parain-
fluenza (13.6%), RV (7.3%), HMPV (6.8%), adenovirus (6.5
%), and influenza (4.8%). 
Eosinophil and neutrophil counts
Eosinophil and neutrophil counts are shown in Table 1. RSV
patients had significantly higher (P=0.002) eosinophil counts
than HMPV patients; however, there was no significant dif-
ference in neutrophil counts. 
*Data are expressed as mean±standard deviation.
HMPV, human metapneumovirus; RSV, respiratory syncytial virus; EDN,
eosinophil derived neurotoxin; ECP, eosinophilic cationic protein.
Parameters
HMPV group
(n=27)
RSV group
(n=101)
P value
Age (month)* 20±11 15±27 <0.001
Sex (M:F) 19:8 66:35 0.684
Serum EDN (ng/mL) 36.3±26.6 39.4±28.1 0.609
Serum ECP (ng/mL) 16.5±15.5 19.4±17.0 0.682
Blood neutrophils (10
3/mL) 3.2±2.6 3.2±2.0 0.618
Blood eosinophils (/mL)* 73.8±109.6 159±176.0 <0.01
Table 1. Demographic features of study population
*% of inpatients positive for these viruses with a wheezing illness.
HMPV, human metapneumovirus; RSV, respiratory syncytial virus; RAD,
reactive airway disease; BA, bronchial asthma.
Illnesses
HMPV group
(n=27)
RSV group
(n=101)
P value
Wheezing illness* 48.1% 82.2% <0.05
Bronchiolitis 30.8% 79.5% <0.01
RAD exacerbation 23.1% 3.6% 0.037
BA exacerbation 46.2% 16.9% 0.068
Table 2. Wheezing illnesses in HMPV and RSV groups 344 C.K. Kim, J. Choi, Z. Callaway, et al.
Wheezing illness
Of these virus-positive cases, 48.1% of HMPV-infected and
82.2% of RSV-infected patients were diagnosed with wheez-
ing illnesses (P<0.05) (Table 2). RSV caused a significantly
higher (P<0.01) proportion of bronchiolitis than HMPV.
Age distribution of HMPV and RSV infection
All patients positive for HMPV or RSV and hospitalized
for wheezing illness at our hospital were divided into three
age groups: <12 months, 13-36 months, and >37 months.
In the 13-36 months range, the proportion of HMPV cases
was significantly greater (P<0.05) than the proportion of RSV
cases, while the opposite was true in children <12 months
(P<0.05). In children >37 months, the proportions of HMPV
and RSV were nearly the same. 
Seasonal incidence of HMPV and RSV infection
The study population investigated for seasonal incidence
consisted of 1,008 children cared for at our hospital from
December 2003 to April 2008 (Fig. 1). RSV infection oc-
curred predominantly in the fall and winter and usually fol-
lowed by peaks of HMPV infection in winter and spring.
Co-infection rates
The co-infection rate in the HMPV group was much higher
when compared to the RSV group (25.9% vs. 5.9%). Among
HMPV patients co-infected with other respiratory viruses,
parainfluenza was the most common (42.9%) followed by
RV (28.6%) and adenovirus (28.6%). Among RSV patients
co-infected with other respiratory viruses, adenovirus was the
most common (66.7%) followed by parainfluenza (16.7%)
and RV (16.7%).
DISCUSSION
To date this is the most comprehensive comparison of HM-
PV- and RSV-induced wheezing illness and the first report
of its kind in Korea. Our results demonstrated HMPV wheez-
ing illnesses exhibited several clinical and epidemiological
differences (i.e., proportion of wheezing illness, age and sea-
sonal distribution, and eosinophil counts) when compared to
RSV wheezing illnesses. Both HMPV and RSV were promi-
nent etiologic agents of wheezing illness. In our study, the
proportions of respiratory HMPV and RSV infections man-
ifesting as wheezing illness were quite substantial (48.1%
and 82.2%, respectively). Several studies have shown a strong
association between HMPV infection and wheezing illness
(2, 10-12, 19), though one study contradicted these results
(13). Another study in particular found HMPV bronchioli-
tis to be an important risk factor for asthma development in
preschool years; in fact, the association was at least as strong
as that found between RSV-bronchiolitis and asthma devel-
opment (20). The proportional breakdown of wheezing ill-
ness manifestations in our HMPV and RSV patients differed
from the few recent studies also comparing them. Bronchioli-
tis was a significantly more common diagnosis in RSV pati-
ents than in HMPV patients in our study (79.5% vs. 30.8%).
Manoha et al. (21) found HMPV and RSV infection mani-
festing as bronchiolitis in nearly equal proportions, while asth-
ma was a significantly more common diagnosis in pediatric
inpatients and outpatients with HMPV. A different study
also found bronchial asthma significantly more prevalent in
HMPV patients (22), in contrast to our results. However,
Garcia-Garcia et al. (16) and Kim et al. (23) studies concur
with our findings that RSV is a significantly frequent cause
Fig. 1. Seasonal incidence
of HMPV and RSV infection
was plotted from Decem-
ber 2003 to April 2008. The
Y-axis represents the pro-
portion of the total number
of patients with a wheezing
illness positive for that res-
piratory virus. 
*proportion of all virus-pos-
itive samples.
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of bronchiolitis. Garcia et al. also found HMPV a more fre-
quent cause of recurrent wheezing. Their results, along with
ours, are congruent with Kahn’s review (24) of HMPV stud-
ies, which found this virus to be an important cause of wheez-
ing illness in early childhood.
There were significant differences in age distribution bet-
ween the HMPV and RSV patients in our study population.
The mean age of patients with HMPV was significantly greater
than the age of RSV patients. RSV infection occurred pre-
dominantly in infants (<12 months), while HMPV was found
mainly in children 12-36 months. These results mirror those
of others (23). Baer et al. (25) reported both a significantly
greater median age of HMPV patients and similar propor-
tions of HMPV and RSV infections in the <12 months age
group (39% and 62%, respectively) compared to our study
subgroup of the same age (29.6% and 63%, respectively).
However, Williams et al. (26) found a younger median age in
their HMPV patients compared to those with RSV-induced
lower respiratory tract infection. In a study of Danish children,
hospitalization for acute respiratory tract infection caused by
HMPV occurred only in very young children (1-6 months)
(22). Regardless of these different results, both HMPV and
RSV predominate in infants and young children as major
causes of severe respiratory illness (24). In our study, as age
increased, HMPV became a more important agent of wheez-
ing illnesses, such as RAD and bronchial asthma. This is an
expected result, as very young children previously infected
with RSV would have partial immunity to the virus allow-
ing HMPV to become more dominant in older children.
Analysis of the seasonal incidence of these two virus infec-
tions in Korea (Fig. 1) showed that although both RSV and
HMPV infections occur throughout the year, there is a gen-
eral trend toward RSV occurring mainly in the fall and win-
ter with HMPV infections following in the spring. Incom-
plete data for the spring of 2008 also demonstrate the pre-
dominance of HMPV in this season and no cases of RSV. An
exception for HMPV was the winter season of 2004/2005,
when this virus was more prevalent than RSV. Kim et al. (23)
also reported a spring peak of HMPV and a fall/early winter
peak of RSV infections in Korean children. Another study
directly comparing the seasonality of RSV and HMPV found
similar trends (21) except for the frequent autumnal occur-
rence of RSV in our study. 
Elevated blood eosinophil counts in RSV bronchiolitis were
an interesting finding, as eosinophilia has been associated with
recurrent wheezing/asthma development later in life (27). In
our study the RSV group displayed eosinophilia when com-
pared to the HMPV group. Therefore, RSV-infected patients
may have a greater chance of developing recurrent wheezing
in the future than HMPV-infected patients. However, a more
detailed study of their immunologic profiles, including cyto-
kine and chemokine profiles, will need to be done to more
accurately assess HMPV’s perturbation of the immune sys-
tem and to further compare the similarities and differences
of these two respiratory viruses from immunologic and patho-
physiologic perspectives.
The rate of co-infection in the HMPV group was much
higher when compared to the RSV group (25.9% vs. 5.9%).
The co-infecting viruses were the same for both groups: parain-
fluenza, RV and adenovirus. The overlapping seasonal distri-
butions (26), tendency to occur in the same patient popula-
tion (infants and young children), and similar degree of patho-
genicity (28) of these two common viruses may help explain
why co-infections have been found in several other studies;
however, there were no cases of HMPV and RSV co-infection
in our study. The higher rate of co-infection in the HMPV
group (25.9%) may also be due to the viral detection meth-
ods used in this study: i.e., multiplex RT-PCR for HMPV,
and IFA for all other viruses (with the exception of RV) from
December 2003 to December 2006, and RT-PCR for all virus-
es, thereafter, until the study endpoint. In general, RT-PCR
is a more sensitive test than IFA for detection of viruses (29),
which may result in more HMPV infections detected. There
are also conflicting results regarding whether disease severity
is associated with co-infection (24). More studies are needed
to answer this question. 
A weakness of this study was the fact that only patients
with infections severe enough to be hospitalized were includ-
ed. Therefore, the prevalence of HMPV- and RSV-induced
wheezing illness in our study population may underestimate
their respective prevalence in the community. Furthermore,
the location of our tertiary care facility is unique in that it is
one of the most densely populated neighborhoods in Korea.
The correlation between degree of crowding and incidence
and severity of lower respiratory tract infection has been de-
monstrated (30). Thus, our results cannot be extrapolated to
the entire population of Korean children. As previously men-
tioned, another weakness was the different viral detection meth-
ods used for HMPV versus the other viruses investigated. 
The clinical relevance of this study is the etiologic deter-
mination of wheezing illness in our study population. From
this point, a longitudinal study is needed to investigate pati-
ents who develop recurrent wheezing and/or asthma. In that
way, association between HMPV and/or RSV infection in early
childhood and later asthma development could be deduced. 
To summarize, our data reveals, first, that HMPV is an im-
portant cause of wheezing illness, though the prevalence of
wheezing illness in RSV-infected patients was notably higher
than the corresponding prevalence in HMPV-infected pati-
ents. Second, age distribution analysis showed RSV infections
occurred in significantly younger patients. Third, seasonal
incidence for the two viruses were also different, though with
some overlapping: RSV infections occurred predominantly
in the winter, while HMPV infections in the spring. Peak
incidence of RSV infection was followed by peak HMPV infec-
tion. Fourth, RSV-infected patients exhibited significantly
higher eosinophil counts without significant difference in neu-
trophil counts. 346 C.K. Kim, J. Choi, Z. Callaway, et al.
In conclusion, HMPV is an important cause of wheezing
illness in infants and young children in Korea. Comparing
HMPV and RSV reveals many epidemiological and clinical
differences, but many questions remain unanswered. A long-
term study should be conducted to determine whether early
childhood infection with this virus leads to recurrent wheez-
ing and/or asthma. The next point of comparison should in-
volve the study of their pathophysiology and immunologic
profiles to determine how HMPV induces wheezing illness. 
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